Walker I R, Ali M A
Can Med Assoc J. 1973 Apr 7;108(7):843-7.
Fetal hemoglobin (F) and hemoglobin A(2) were estimated in 35 patients with malignant hematological disorders. In 9 out of 10 patients with morphological and cytochemical features of acute myeloblastic leukemia the hemoglobin F was greater than 2%. Of the other 25 patients investigated only one patient with polycythemia rubra vera had a hemoglobin F level of more than 2%. Estimation of fetal hemoglobin may be of value in the classification of acute leukemias and the increased level observed probably reflects disturbed hemoglobin synthesis in the acute myeloblastic type.
对35例恶性血液病患者进行了胎儿血红蛋白(F)和血红蛋白A2的检测。在10例具有急性髓细胞白血病形态学和细胞化学特征的患者中,有9例胎儿血红蛋白大于2%。在其他25例接受调查的患者中,只有1例真性红细胞增多症患者的胎儿血红蛋白水平超过2%。胎儿血红蛋白的检测可能对急性白血病的分类有价值,观察到的其水平升高可能反映了急性髓细胞型血红蛋白合成的紊乱。